Víctor M Alfaro-Magallanes1, Laura Barba-Moreno2, Nuria Romero-Parra2, Beatriz Rael2, Pedro J Benito2, Dorine W Swinkels3,4, Coby M Laarakkers3,4, Ángel E Díaz5, Ana B Peinado2. 1. LFE Research Group, Department of Health and Human Performance. Faculty of Physical Activity and Sport Science (INEF), Universidad Politécnica de Madrid, Martín Fierro, 7, 28040, Madrid, Spain. vm.alfaro@upm.es. 2. LFE Research Group, Department of Health and Human Performance. Faculty of Physical Activity and Sport Science (INEF), Universidad Politécnica de Madrid, Martín Fierro, 7, 28040, Madrid, Spain. 3. Department of Laboratory Medicine, Translational Metabolic Laboratory (TML 830), Radboud University Medical Center, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands. 4. Hepcidinanalysis.Com, Geert Grooteplein 10 (830), 6525 GA, Nijmegen, The Netherlands. 5. Clinical Laboratory, National Center of Sport Medicine, Health and Sports Department, AEPSAD, Madrid, Spain.
Abstract
PURPOSE: Menstrual cycle phase affects resting hepcidin levels, but such effects on the hepcidin response to exercise are still unclear. Thus, we investigated the hepcidin response to running during three different menstrual cycle phases. METHODS: Twenty-one endurance-trained eumenorrheic women performed three identical interval running protocols during the early-follicular phase (EFP), late-follicular phase (LFP), and mid-luteal phase (MLP). The protocol consisted of 8 × 3 min bouts at 85% of the maximal aerobic speed, with 90-s recovery. Blood samples were collected pre-exercise and at 0 h, 3 h and 24 h post-exercise. RESULTS: Data presented as mean ± SD. Ferritin were lower in the EFP than the LFP (34.82 ± 16.44 vs 40.90 ± 23.91 ng/ml, p = 0.003), while iron and transferrin saturation were lower during the EFP (58.04 ± 19.70 µg/dl, 14.71 ± 5.47%) compared to the LFP (88.67 ± 36.38 µg/dl, 22.22 ± 9.54%; p < 0.001) and the MLP (80.20 ± 42.05 µg/dl, 19.87 ± 10.37%; p = 0.024 and p = 0.045, respectively). Hepcidin was not affected by menstrual cycle (p = 0.052) or menstrual cycle*time interaction (p = 0.075). However, when comparing hepcidin at 3 h post-exercise, a moderate and meaningful effect size showed that hepcidin was higher in the LFP compared to the EFP (3.01 ± 4.16 vs 1.26 ± 1.25 nMol/l; d = 0.57, CI = 0.07-1.08). No effect of time on hepcidin during the EFP was found either (p = 0.426). CONCLUSION: The decrease in iron, ferritin and TSAT levels during the EFP may mislead the determination of iron status in eumenorrheic athletes. However, although the hepcidin response to exercise appears to be reduced in the EFP, it shows no clear differences between the phases of the menstrual cycle (clinicaltrials.gov: NCT04458662).
PURPOSE: Menstrual cycle phase affects resting hepcidin levels, but such effects on the hepcidin response to exercise are still unclear. Thus, we investigated the hepcidin response to running during three different menstrual cycle phases. METHODS: Twenty-one endurance-trained eumenorrheic women performed three identical interval running protocols during the early-follicular phase (EFP), late-follicular phase (LFP), and mid-luteal phase (MLP). The protocol consisted of 8 × 3 min bouts at 85% of the maximal aerobic speed, with 90-s recovery. Blood samples were collected pre-exercise and at 0 h, 3 h and 24 h post-exercise. RESULTS: Data presented as mean ± SD. Ferritin were lower in the EFP than the LFP (34.82 ± 16.44 vs 40.90 ± 23.91 ng/ml, p = 0.003), while iron and transferrin saturation were lower during the EFP (58.04 ± 19.70 µg/dl, 14.71 ± 5.47%) compared to the LFP (88.67 ± 36.38 µg/dl, 22.22 ± 9.54%; p < 0.001) and the MLP (80.20 ± 42.05 µg/dl, 19.87 ± 10.37%; p = 0.024 and p = 0.045, respectively). Hepcidin was not affected by menstrual cycle (p = 0.052) or menstrual cycle*time interaction (p = 0.075). However, when comparing hepcidin at 3 h post-exercise, a moderate and meaningful effect size showed that hepcidin was higher in the LFP compared to the EFP (3.01 ± 4.16 vs 1.26 ± 1.25 nMol/l; d = 0.57, CI = 0.07-1.08). No effect of time on hepcidin during the EFP was found either (p = 0.426). CONCLUSION: The decrease in iron, ferritin and TSAT levels during the EFP may mislead the determination of iron status in eumenorrheic athletes. However, although the hepcidin response to exercise appears to be reduced in the EFP, it shows no clear differences between the phases of the menstrual cycle (clinicaltrials.gov: NCT04458662).
Authors: Weiwen Chai; Yukiko Morimoto; Robert V Cooney; Adrian A Franke; Yurii B Shvetsov; Loïc Le Marchand; Christopher A Haiman; Laurence N Kolonel; Marc T Goodman; Gertraud Maskarinec Journal: J Am Coll Nutr Date: 2017-06-19 Impact factor: 3.169
Authors: Irena Auersperger; Bojan Knap; Ales Jerin; Rok Blagus; Mitja Lainscak; Milan Skitek; Branko Skof Journal: Int J Sport Nutr Exerc Metab Date: 2012-02 Impact factor: 4.599
Authors: Laura Barba-Moreno; Víctor M Alfaro-Magallanes; Xanne A K Janse de Jonge; Angel E Díaz; Rocío Cupeiro; Ana B Peinado Journal: Eur J Sport Sci Date: 2020-12-17 Impact factor: 4.050
Authors: Irena Auersperger; Branko Škof; Bojan Leskošek; Bojan Knap; Aleš Jerin; Mitja Lainscak Journal: PLoS One Date: 2013-03-05 Impact factor: 3.240
Authors: Víctor M Alfaro-Magallanes; Laura Barba-Moreno; Beatriz Rael; Nuria Romero-Parra; Miguel A Rojo-Tirado; Pedro J Benito; Dorine W Swinkels; Coby M Laarakkers; Ángel E Díaz; Ana B Peinado Journal: Scand J Med Sci Sports Date: 2020-12-07 Impact factor: 4.221